£51.00

LAP Lambert Academic Publishing Development Of Potential Reverse Transcriptase Inhibitors: Using Molecular Modeling Studies

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£51 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical
Generating forecast…
£51.00 £48.45 £49.47 £50.49 £51.51 £52.53 £53.55 27 June 2026 17 July 2026 06 August 2026 26 August 2026 16 September 2026

Price Distribution

Price distribution over 82 days • 1 price levels

Days at Price
82 days 0 21 41 62 82 £51 Days at Price

Price Analysis

Most common price: £51 (82 days, 100.0%)

Price range: £51 - £51

Price levels: 1 different prices over 82 days

Description

Non-nucleoside reverse transcriptase inhibitors (NNRTI) has a definitive role and most commonly used in treatment of HIV infection. NNRTI act by binding to specific binding site (non-nucleoside binding pocket-NNBP) in reverse transcriptase (RT) enzyme. With the objective of developing efficient NNRTI, we have designed various Isatin analogs for effective treatment of AIDS and were subjected to molecular docking studies on five different crystal structures of RT complexed with five different ligands Nevirapine, Delaviridine, Efavirenz, Etravirine, and Rilpivirine. Combined dock-score of compound N21, N11, N23 was found to be comparable with standards indicated that Isatin analogs have good binding affinity for NNBP. Docking results suggested that these types of compounds could be binding in the NNRTI binding site in a similar mode to a known non-nucleoside inhibitors. ADME properties of Isatin analogs were also analyzed using Qikprop 2.5 tool of Schrodinger software. In the present thesis applications of new computational tools for drug discovery are explored and the details of methodology, results, discussion and conclusions derived are presented.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Computer Design of New Heterocyclic Molecules as Drug Precursors: New candidate drugs in the treatment of cancer and microbial infections using bioinformatics and biostatistics tools
81% match

Computer Design of New Heterocyclic Molecules as Drug Precursors: New candidate drugs in the treatment of cancer and microbial infections using bioinformatics and biostatistics tools

LAP Lambert Academic Publishing

£55.00 13 Aug 2026
HIV1 Nef binding to hTE8 protein: insights from computational biology: Homology modeling, virtual protein-protein docking and Molecular Dynamics Simulation
80% match

HIV1 Nef binding to hTE8 protein: insights from computational biology: Homology modeling, virtual protein-protein docking and Molecular Dynamics Simulation

LAP Lambert Academic Publishing

£41.00 16 Sep 2026
COMPUTATIONAL ASSESSMENT OF DIFFERENT CANCER CONTROLLING DRUGS: Pharmacological & Toxicological Assessment through an In Silico Approach
80% match

COMPUTATIONAL ASSESSMENT OF DIFFERENT CANCER CONTROLLING DRUGS: Pharmacological & Toxicological Assessment through an In Silico Approach

LAP Lambert Academic Publishing

£61.00 16 Sep 2026
Molecular Modeling, Docking and 3D QSAR Studies of MtB TNMO Enzyme
80% match

Molecular Modeling, Docking and 3D QSAR Studies of MtB TNMO Enzyme

LAP Lambert Academic Publishing

£51.00 16 Sep 2026
Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)
79% match

Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)

£114.00 14 Sep 2026
Computaional Design and Evaluation of Antibacterial agents
78% match

Computaional Design and Evaluation of Antibacterial agents

LAP Lambert Academic Publishing

£56.00 16 Sep 2026
Computational Drug Discovery and Design: 1762 (Methods in Molecular Biology, 1762)
77% match

Computational Drug Discovery and Design: 1762 (Methods in Molecular Biology, 1762)

Humana

£89.28 07 Aug 2026
Applied Computer-Aided Drug Design: Models and Methods
77% match

Applied Computer-Aided Drug Design: Models and Methods

£71.43 17 Aug 2026
77% match

Integrating Artificial Intelligence with Virtual Screening: A New Era in Drug Discovery

Elsevier

£157.99 06 Aug 2026
Structures and Functions of Retroviral RNAs: The Multiple Facets of the Retroviral Genome (Biology Series: Nucleic Acids Set, 1)
77% match

Structures and Functions of Retroviral RNAs: The Multiple Facets of the Retroviral Genome (Biology Series: Nucleic Acids Set, 1)

Wiley

£111.99 18 Aug 2026
New Anticancer Pyrimidine Nucleoside Analogs
77% match

New Anticancer Pyrimidine Nucleoside Analogs

LAP Lambert Academic Publishing

£65.00 15 Sep 2026
Advances in Antiviral Drug Design (Volume 4)
77% match

Advances in Antiviral Drug Design (Volume 4)

Elsevier

£53.74 05 Aug 2026
Recent Advances in Molecular Docking: Methods, Tools, and Applications
77% match

Recent Advances in Molecular Docking: Methods, Tools, and Applications

Elsevier

£135.56 05 Aug 2026
Structural Bioinformatics Tools for Drug Design: Extraction of Biologically Relevant Information from Structural Databases (SpringerBriefs in Biochemistry and Molecular Biology)
76% match

Structural Bioinformatics Tools for Drug Design: Extraction of Biologically Relevant Information from Structural Databases (SpringerBriefs in Biochemistry and Molecular Biology)

Springer

£44.85 15 Sep 2026
Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery
76% match

Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery

IntechOpen

£119.00 29 Aug 2026
Rational Drug Design: 108 (The IMA Volumes in Mathematics and its Applications, 108)
76% match

Rational Drug Design: 108 (The IMA Volumes in Mathematics and its Applications, 108)

Springer

£74.91 08 Aug 2026
Reinventing The Breast Cancer: A System Biology Approach
76% match

Reinventing The Breast Cancer: A System Biology Approach

LAP Lambert Academic Publishing

£52.00 13 Sep 2026
Genetic Algorithm for Ab Initio Protein Structure Prediction
76% match

Genetic Algorithm for Ab Initio Protein Structure Prediction

LAP Lambert Academic Publishing

£64.00 16 Sep 2026
Computer-Aided Drug Discovery (Methods in Pharmacology and Toxicology)
76% match

Computer-Aided Drug Discovery (Methods in Pharmacology and Toxicology)

Humana

£73.14 05 Aug 2026
Quick Guideline for Computational Drug Design
76% match

Quick Guideline for Computational Drug Design

Bentham Science Publishers

£81.30 10 Aug 2026
Drug Repurposing and Computational Drug Discovery: Strategies and Advances
76% match

Drug Repurposing and Computational Drug Discovery: Strategies and Advances

£109.32 15 Sep 2026
Computational Methods for GPCR Drug Discovery: 1705 (Methods in Molecular Biology, 1705)
76% match

Computational Methods for GPCR Drug Discovery: 1705 (Methods in Molecular Biology, 1705)

Humana

£81.74 07 Aug 2026
The development of a clique finding algorithm and its use: in comparing RNA tertiary structures
76% match

The development of a clique finding algorithm and its use: in comparing RNA tertiary structures

LAP Lambert Academic Publishing

£64.00 16 Sep 2026
Insilico study of Some Anticonvulsant Compounds
76% match

Insilico study of Some Anticonvulsant Compounds

£78.00 15 Sep 2026